FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916484820> ?p ?o ?g. }

• W2916484820 endingPage "1650" @default.
• W2916484820 startingPage "1634" @default.
• W2916484820 abstract "Rationale: Growing evidence indicates that intracellular reactive oxygen species (ROS) accumulation is a critical factor in the development of osteoporosis by triggering osteoclast formation and function. Pseurotin A (Pse) is a secondary metabolite isolated from Aspergillus fumigatus with antioxidant properties, recently shown to exhibit a wide range of potential therapeutic applications. However, its effects on osteoporosis remain unknown. This study aimed to explore whether Pse, by suppressing ROS level, is able to inhibit osteoclastogenesis and prevent the bone loss induced by estrogen-deficiency in ovariectomized (OVX) mice. Methods: The effects of Pse on receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL)-induced osteoclastogenesis and bone resorptive function were examined by tartrate resistant acid phosphatase (TRAcP) staining and hydroxyapatite resorption assay. 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) was used to detect intracellular ROS production in vitro. Western blot assay was used to identify proteins associated with ROS generation and scavenging as well as ROS-mediated signaling cascades including mitogen-activated protein kinases (MAPKs), NF-κB pathways, and nuclear factor of activated T cells 1 (NFATc1) signaling. The expression of osteoclast-specific genes was assessed by qPCR. The in vivo potential of Pse was determined using an OVX mouse model administered with Pse or vehicle for 6 weeks. In vivo ROS production was assessed by intravenous injection of dihydroethidium (DHE) into OVX mice 24h prior to killing. After sacrifice, the bone samples were analyzed using micro-CT and histomorphometry to determine bone volume, osteoclast activity, and ROS level ex vivo. Results: Pse was demonstrated to inhibit osteoclastogenesis and bone resorptive function in vitro, as well as the downregulation of osteoclast-specific genes including Acp5 (encoding TRAcP), Ctsk (encoding cathepsin K), and Mmp9 (encoding matrix metalloproteinase 9). Mechanistically, Pse suppressed intracellular ROS level by inhibiting RANKL-induced ROS production and enhancing ROS scavenging enzymes, subsequently suppressing MAPK pathway (ERK, P38, and JNK) and NF-κB pathways, leading to the inhibition of NFATc1 signaling. Micro-CT and histological data indicated that OVX procedure resulted in a significant bone loss, with dramatically increased the number of osteoclasts on the bone surface as well as increased ROS level in the bone marrow microenvironment; whereas Pse supplementation was capable of effectively preventing these OVX-induced changes. Conclusion: Pse was demonstrated for the first time as a novel alternative therapy for osteoclast-related bone diseases such as osteoporosis through suppressing ROS level." @default.
• W2916484820 created "2019-03-02" @default.
• W2916484820 creator A5000510528 @default.
• W2916484820 creator A5001770817 @default.
• W2916484820 creator A5002499892 @default.
• W2916484820 creator A5002608922 @default.
• W2916484820 creator A5003299386 @default.
• W2916484820 creator A5005346983 @default.
• W2916484820 creator A5006131292 @default.
• W2916484820 creator A5014470814 @default.
• W2916484820 creator A5016928311 @default.
• W2916484820 creator A5027735250 @default.
• W2916484820 creator A5046788364 @default.
• W2916484820 creator A5051221710 @default.
• W2916484820 creator A5070570063 @default.
• W2916484820 creator A5074339191 @default.
• W2916484820 creator A5078961072 @default.
• W2916484820 date "2019-01-01" @default.
• W2916484820 modified "2023-10-14" @default.
• W2916484820 title "Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species" @default.
• W2916484820 cites W1523693806 @default.
• W2916484820 cites W169008966 @default.
• W2916484820 cites W1964829601 @default.
• W2916484820 cites W1966522800 @default.
• W2916484820 cites W1967647163 @default.
• W2916484820 cites W1971720206 @default.
• W2916484820 cites W1974120192 @default.
• W2916484820 cites W1978961990 @default.
• W2916484820 cites W1985260819 @default.
• W2916484820 cites W1988434255 @default.
• W2916484820 cites W1990186160 @default.
• W2916484820 cites W1993812666 @default.
• W2916484820 cites W1994403682 @default.
• W2916484820 cites W1997474765 @default.
• W2916484820 cites W2002315265 @default.
• W2916484820 cites W2002483881 @default.
• W2916484820 cites W2002831974 @default.
• W2916484820 cites W2006950202 @default.
• W2916484820 cites W2013184426 @default.
• W2916484820 cites W2016053535 @default.
• W2916484820 cites W2017372504 @default.
• W2916484820 cites W2027872174 @default.
• W2916484820 cites W2028525107 @default.
• W2916484820 cites W2035108128 @default.
• W2916484820 cites W2041100916 @default.
• W2916484820 cites W2044147730 @default.
• W2916484820 cites W2049663776 @default.
• W2916484820 cites W2056831005 @default.
• W2916484820 cites W2061338233 @default.
• W2916484820 cites W2063426382 @default.
• W2916484820 cites W2066574904 @default.
• W2916484820 cites W2068149973 @default.
• W2916484820 cites W2071768625 @default.
• W2916484820 cites W2076485183 @default.
• W2916484820 cites W2079499339 @default.
• W2916484820 cites W2082503449 @default.
• W2916484820 cites W2083886898 @default.
• W2916484820 cites W2093252878 @default.
• W2916484820 cites W2095427555 @default.
• W2916484820 cites W2098085126 @default.
• W2916484820 cites W2098975624 @default.
• W2916484820 cites W2101051981 @default.
• W2916484820 cites W2101140158 @default.
• W2916484820 cites W2111141380 @default.
• W2916484820 cites W2114111268 @default.
• W2916484820 cites W2122518329 @default.
• W2916484820 cites W2123346255 @default.
• W2916484820 cites W2130423015 @default.
• W2916484820 cites W2131136431 @default.
• W2916484820 cites W2143813009 @default.
• W2916484820 cites W2147993424 @default.
• W2916484820 cites W2167722126 @default.
• W2916484820 cites W2170597525 @default.
• W2916484820 cites W2199224494 @default.
• W2916484820 cites W2215407483 @default.
• W2916484820 cites W2514784424 @default.
• W2916484820 cites W2564414342 @default.
• W2916484820 cites W2604121576 @default.
• W2916484820 cites W2607963821 @default.
• W2916484820 cites W2767054503 @default.
• W2916484820 cites W2767815049 @default.
• W2916484820 cites W2810629031 @default.
• W2916484820 cites W2897021222 @default.
• W2916484820 cites W2951090125 @default.
• W2916484820 doi "https://doi.org/10.7150/thno.30206" @default.
• W2916484820 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6485188" @default.
• W2916484820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31037128" @default.
• W2916484820 hasPublicationYear "2019" @default.
• W2916484820 type Work @default.
• W2916484820 sameAs 2916484820 @default.
• W2916484820 citedByCount "138" @default.
• W2916484820 countsByYear W29164848202019 @default.
• W2916484820 countsByYear W29164848202020 @default.
• W2916484820 countsByYear W29164848202021 @default.
• W2916484820 countsByYear W29164848202022 @default.
• W2916484820 countsByYear W29164848202023 @default.
• W2916484820 crossrefType "journal-article" @default.
• W2916484820 hasAuthorship W2916484820A5000510528 @default.

• next